Literature DB >> 11072264

Neuropathology of Alzheimer's disease and related disorders.

D P Perl1.   

Abstract

Neuropathologic studies have done much to define the range of disorders that may underlie dementia. By far, the most important disease entity is Alzheimer's disease, with its characteristic neurofibrillary tangles and senile plaques. The neuropathologic distinction between Alzheimer's disease, particularly in its early stages, and normal aging is a subject of intense interest, attracting considerable current research activity. The neuropathologic substrate of other entities that may lead to dementia is extensive and, in the absence of biologic markers for most of these disorders, postmortem examination remains the only definitive method for establishing a diagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 11072264     DOI: 10.1016/s0733-8619(05)70229-2

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  10 in total

1.  Screening of APP interaction proteins by DUALmembrane yeast two-hybrid system.

Authors:  You Yu; Yinan Li; Yan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration.

Authors:  Alexandra A Herzlich; Xiaoyan Ding; Defen Shen; Robert J Ross; Jingsheng Tuo; Chi-Chao Chan
Journal:  Open Biol J       Date:  2009-01-01

3.  Imaging the Alzheimer brain.

Authors:  J Wesson Ashford; Ahmad Salehi; Ansgar Furst; Peter Bayley; Giovanni B Frisoni; Clifford R Jack; Osama Sabri; Maheen M Adamson; Kerry L Coburn; John Olichney; Norbert Schuff; Daniel Spielman; Steven D Edland; Sandra Black; Allyson Rosen; David Kennedy; Michael Weiner; George Perry
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 4.  Acetylcholine receptors in dementia and mild cognitive impairment.

Authors:  Osama Sabri; Kai Kendziorra; Henrike Wolf; Hermann-Josef Gertz; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

Review 5.  Dementia syndromes: evaluation and treatment.

Authors:  Kevin R Scott; Anna M Barrett
Journal:  Expert Rev Neurother       Date:  2007-04       Impact factor: 4.618

Review 6.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 7.  Biological fluid biomarkers in neurodegenerative parkinsonism.

Authors:  Michael Eller; David R Williams
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

8.  Single-channel quantitative multiplex reverse transcriptase-polymerase chain reaction for large numbers of gene products differentiates nondemented from neuropathological Alzheimer's disease.

Authors:  Stavros Therianos; Min Zhu; Eunice Pyun; Paul D Coleman
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

9.  Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study.

Authors:  Agostino Chiaravalloti; Francesco Ursini; Alessandro Fiorentini; Gaetano Barbagallo; Alessandro Martorana; Giacomo Koch; Mario Tavolozza; Orazio Schillaci
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

10.  Peroxisome proliferator-activated receptor and age-related macular degeneration.

Authors:  Alexandra A Herzlich; Jingsheng Tuo; Chi-Chao Chan
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.